Celldex Therapeutics Inc. (CLDX)
NASDAQ · Healthcare
Celldex Therapeutics Inc. Net Income 2009–2025
Celldex Therapeutics Inc. annual/quarterly net income history and growth rate from 2023 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Celldex Therapeutics Inc. net income for the quarter ending March 31, 2026 was -78.7 M, a 46.27% increase year-over-year.
- Celldex Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -231.2 M.
- Celldex Therapeutics Inc. annual net income for 2025 was -258.8 M, a 63.91% increase from 2024.
- Celldex Therapeutics Inc. annual net income for 2024 was -157.9 M, a 11.62% increase from 2023.
- Celldex Therapeutics Inc. annual net income for 2023 was -141.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Celldex Therapeutics Inc. Net Income — FAQ
Celldex Therapeutics Inc. (CLDX) net income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Celldex Therapeutics Inc.'s net income?
Celldex Therapeutics Inc. (CLDX) reported net income of -$259M for fiscal 2025.
Where can I see CLDX's net income history?
The chart and table above show Celldex Therapeutics Inc.'s net income by year and by quarter, including the growth rate.